Αρχική World News Extended Lymphadenectomy Does Not Improve DFS or OS Among Patients with Localised... World News Extended Lymphadenectomy Does Not Improve DFS or OS Among Patients with Localised Muscle Invasive Bladder Cancer Από Ogkologos - 4 Νοεμβρίου, 2024 2013 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the SWOG S1011 study Source ΠΑΡΟΜΟΙΑ ΑΡΘΡΑΠΕΡΙΣΣΟΤΕΡΑ ΑΠΟ ΤΟΝ ΔΗΜΙΟΥΡΓΟ Ahead of the Special European Council Meeting on 26-27 November, ESMO Calls on EU Governments to Continue Support for the Cancer Mission European Parliament backs key priorities advocated by ESMO for cancer research and innovation FDA approves giredestrant in combination with everolimus for ER-positive, HER2-negative, ESR1-mutated locally advanced or metastatic breast cancer MOST POPULAR How Anxiety Impacts People With Cancer and How to Cope 10 Φεβρουαρίου, 2022 Adjuvant Olaparib Continues to Improve Multiple Outcomes in Patients with Germline... 31 Αυγούστου, 2026 ESMO Launches First Congress on Artificial Intelligence and Digital Oncology: A... 12 Νοεμβρίου, 2025 Q&A: Learning About the Cancer Care Challenges LGBTQ+ People Face 1 Μαΐου, 2024 Φόρτωση περισσοτέρων HOT NEWS Malaria Vaccine Approved by W.H.O. Could Save Tens Of Thousands Of... FDA Approves Lutetium Lu 177 Dotatate for Paediatric Patients 12 Years... Listening to Patient Narratives Steps towards a smokefree society